Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations

Nature Reviews. Drug Discovery
T Scott StroupJeffrey A Lieberman

Abstract

More than 50 years after the introduction of modern pharmacotherapies for schizophrenia, there remains a tremendous need for therapeutic advances. A second generation of antipsychotic drugs, introduced over the past 15 years, has provided uncertain advantages over the first-generation drugs. This paper reviews the designs of studies that evaluate the effectiveness of putative antipsychotic drugs. Data from the trials needed to achieve regulatory approval do not meet all the needs of clinicians and policy makers. Practical and large, simple trials that evaluate the comparative effectiveness of antipsychotic drugs in real-world settings can help to meet these needs once a drug has reached the market.

References

Aug 1, 1990·Archives of General Psychiatry·T Van PuttenJ Mintz
Jan 1, 1973·Archives of General Psychiatry·G E Hogarty, S C Goldberg
Jun 1, 1994·The American Journal of Psychiatry·S R Marder, R C Meibach
Jun 1, 1994·Clinical Pharmacology and Therapeutics·J A DiMasiL Lasagna
Feb 1, 1994·Journal of Clinical Pharmacology·K I KaitinL Lasagna
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS Hamilton
Jan 1, 1996·Schizophrenia Bulletin·J VolavkaM Meisner
Dec 1, 1996·Archives of General Psychiatry·S KumraJ L Rapoport
Jun 1, 1997·The American Journal of Psychiatry·M F GreenJ Mintz
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M BeasleyJ N Beuzen
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Aug 12, 1998·The American Journal of Psychiatry·R W BuchananG D Pearlson
Oct 31, 1998·BMJ : British Medical Journal·R Peto, C Baigent
Oct 31, 1998·BMJ : British Medical Journal·B Thornley, C Adams
Jun 8, 1991·Journal of Health Economics·J A DiMasiL Lasagna
Apr 6, 1999·Schizophrenia Research·G D Tollefson, T M Sanger
Apr 8, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D G DanielM Lakshminarayanan
Jan 1, 1997·American Journal of Therapeutics·K I Kaitin, M Manocchia
Sep 4, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D A RevickiC M Beasley
Jan 25, 2000·The British Journal of Psychiatry : the Journal of Mental Science·M HotopfG Lewis
Feb 13, 2001·Biological Psychiatry·G D TollefsonUNKNOWN Lilly Resistant Schizophrenia Study Group
Oct 31, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·L CitromeJ A Lieberman

❮ Previous
Next ❯

Citations

Nov 16, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Jelveh LamehDouglas W Bonhaus
Feb 5, 2008·Schizophrenia Bulletin·T Scott Stroup, John R Geddes
Feb 1, 2008·Schizophrenia Bulletin·Stefan LeuchtJohn M Kane
Jan 24, 2013·Therapeutic Advances in Chronic Disease·Erik Johnsen, Rune A Kroken
Sep 2, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Yona GeffenAbraham Weizman
Feb 5, 2008·Schizophrenia Research·Rajiv TandonUNKNOWN Section of Pharmacopsychiatry, World Psychiatric Association
Jan 20, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C ArangoUNKNOWN ZIS Study Group
Sep 30, 2010·Neuropathology and Applied Neurobiology·L ZhanJ Nasir
Jan 1, 2011·Human Psychopharmacology·Marek Krzystanek, Irena Krupka-Matuszczyk
Feb 26, 2010·The Australian and New Zealand Journal of Psychiatry·Stanley V CattsRussell W Evans
Jul 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Scott Y H KimEric D Caine
Jan 24, 2019·The Korean Journal of Pain·Sang Wook ShinKyung Hoon Kim
Jul 8, 2018·BMC Medical Research Methodology·Helene KarcherUNKNOWN GetReal Consortium Work Package 2
Feb 14, 2007·ChemMedChem·Teresa TarragoErnest Giralt
Sep 29, 2020·Frontiers in Cellular Neuroscience·Daisuke IbiMasayuki Hiramatsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.